Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • 23andMe management update

    23andMe Inc., Mountain View, Calif. Business: Diagnostic Hired: Jill Hagenkord as CMO, a newly created position, formerly SVP of medical strategy at Invitae Corp.

    Published on 4/21/2014
  • Astellas management update

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Pharmaceuticals Promoted: Jeffrey Bloss to SVP of medical affairs Americas in Astellas' Astellas Scientific and Medical Affairs (ASMA) Inc. division from VP of …

    Published on 4/21/2014
  • Dyax management update

    Dyax Corp. (NASDAQ:DYAX), Burlington, Mass. Business: Inflammation, Ophthalmic Hired: Todd Bazemore as EVP and chief commercial officer, formerly VP of managed markets at the Sunovion Pharmaceuticals Inc. subsidiary of …

    Published on 4/21/2014
  • GNS Healthcare management update

    GNS Healthcare Inc., Cambridge, Mass. Business: Pharmacogenetics Hired: Mark Pottle as CFO, formerly CFO of N-of-One Inc.

    Published on 4/21/2014
  • Harvard Apparatus Regenerative management update

    Harvard Apparatus Regenerative Technology Inc. (NASDAQ:HART), Holliston, Mass. Business: Gene/Cell therapy Hired: Saverio La Francesca, a cardiothoracic surgeon, as CMO; formerly director of the Exvivo lung perfusion …

    Published on 4/21/2014
  • Heart Metabolics board of directors update

    Heart Metabolics Ltd., London, U.K. Business: Cardiovascular Appointed: Robert Adelman, managing partner at venBio; Alan O'Connell, partner at Seroba Kernel Life Sciences; and Stephen Thompson, managing director of …

    Published on 4/21/2014
  • Iconic board of directors update

    Iconic Therapeutics Inc., Atlanta, Ga. Business: Ophthalmic, Cancer Appointed: Todd Foley, managing director at MPM Capital; Johan Kordel, senior partner at Lundbeckfond Ventures; and Bruce Robertson, managing director …

    Published on 4/21/2014
  • Iconic management update

    Iconic Therapeutics Inc., Atlanta, Ga. Business: Ophthalmic, Cancer Hired: William Greene, a venture partner at MPM Capital, as CEO; he succeeds Kirk Dornbush, who becomes president and COO, while remaining a director

    Published on 4/21/2014
  • Karyopharm management update

    Karyopharm Therapeutics Inc. (NASDAQ:KPTI), Natick, Mass. Business: Cancer, Inflammation Hired: Christopher Primiano as VP, general counsel and secre-tary, formerly counsel at Wilmer Cutler Pickering Hale and Dorr LLP

    Published on 4/21/2014
  • Kite Pharma management update

    Kite Pharma Inc., Los Angeles, Calif. Business: Cancer Promoted: Margo Roberts to CSO from VP of research Transitioned: Cynthia Butitta to COO, while remaining CFO

    Published on 4/21/2014
  • Nora Therapeutics board of directors update

    Nora Therapeutics Inc., Palo Alto, Calif. Business: Genitourinary Appointed: Heath Lukatch, partner at Novo Ventures

    Published on 4/21/2014
  • PanOptica board of directors update

    PanOptica Inc., Mount Arlington, N.J. Business: Ophthalmic Appointed: Thomas Dyrberg, senior partner at Novo Ventures

    Published on 4/21/2014
  • Tokai management update

    Tokai Pharmaceuticals Inc., Cambridge, Mass. Business: Cancer Hired: Karen Ferrante as head of R&D and CMO, formerly oncology therapeutic area head and Cambridge, Mass. site head at Takeda Pharmaceutical Co. Ltd.

    Published on 4/21/2014
  • TransTech management update

    TransTech Pharma LLC, High Point, N.C. Business: High throughput screening, Chemistry Transitioned: Stephen Holcombe to president of TransTech and affiliate company High Point Pharmaceuticals LLC from SVP of TransTech, …

    Published on 4/21/2014
  • Wilson Therapeutics board of directors update

    Wilson Therapeutics AB, Stockholm, Sweden Business: Endocrine/Metabolic Appointed: Genghis Lloyd-Harris, partner at Abingworth; and Bali Muralidhar, partner at MVM Life Science Partners

    Published on 4/21/2014
  • WuXi management update

    WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Business: Supply/Service Hired: Steve Yang as EVP and COO, formerly VP and head of Asia and emerging markets for the innovative medicines unit (iMED) at AstraZeneca plc; …

    Published on 4/21/2014
  • Amarantus Bioscience management update

    Amarantus Bioscience Holdings Inc. (OTCQB:AMBS), San Francisco, Calif. Business: Neurology, Cardiovascular Hired: Charlotte Keywood as CMO of Amarantus' therapeutics division, formerly CMO of Addex Therapeutics Ltd.

    Published on 4/14/2014
  • Atara Biotherapeutics management update

    Atara Biotherapeutics Inc., Brisbane, Calif. Business: Cancer, Renal Hired: Mitchall Clark as chief regulatory and quality assurance officer, formerly EVP and CFO of Onyx Pharmaceuticals Inc., which Amgen Inc. acquired

    Published on 4/14/2014
  • AthernoNova management update

    AtheroNova Inc. (OTCBB:AHRO), Irvine, Calif. Business: Cardiovascular Hired: Randolph Johnson as COO, formerly chief of technology development and VP of research at KAI Pharmaceuticals Inc., which Amgen Inc. acquired

    Published on 4/14/2014
  • Biogen Idec management update

    Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Business: Biopharmaceuticals Hired: Adam Koppel as SVP and chief strategy officer, a newly created role, effective May 15, formerly a managing director at Brookside Capital,…

    Published on 4/14/2014
  • Cequr management update

    Cequr S.A., Montreux, Switzerland Business: Endocrine/Metabolic, Drug delivery Hired: Douglas Lawrence as CEO, formerly VP for the insulin injection business at Becton Dickinson and Co.; he succeeds James Peterson, who …

    Published on 4/14/2014
  • Chimerix management update

    Chimerix Inc. (NASDAQ:CMRX), Durham, N.C. Business: Infectious Resigned: Kenneth Moch as president and CEO; he is succeeded by CMO Michelle Beery

    Published on 4/14/2014
  • Convoy Therapeutics management update

    Convoy Therapeutics Inc., Oro Valley, Ariz. Business: Dermatology Hired: Mary Spellman as CMO, formerly CMO of Revance Therapeutics Inc.

    Published on 4/14/2014
  • Deciphera management update

    Deciphera Pharmaceuticals LLC, Lawrence, Kan. Business: Cancer Hired: Michael Taylor as president, CEO and a director, formerly CEO of Ensemble Therapeutics Corp.; he succeeds Daniel Flynn, who becomes CSO and remains a…

    Published on 4/14/2014
  • e-Therapeutics management update

    e-Therapeutics plc (LSE:ETX), Newcastle upon Tyne, U.K. Business: Infectious, Cancer Hired: Steve Medlicott as finance director

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993